Juho Jalkanen

Company: Faron Pharmaceuticals

Job title: Chief Executive Officer

Bio:

Dr. Juho Jalkanen is an experienced biopharmaceutical industry executive with extensive leadership experience across key functional areas including operations, business development, clinical development, medical and regulatory affairs.

Dr. Jalkanen earned a Master´s degree in economics and business administration from the Turku School of Economics and both his M.D. and Ph.D. degrees from the University of Turku. He is a fully licensed general practitioner and specialist in vascular surgery.

Seminars:

Fireside Chat: Aligning Regulatory & Funding Strategies to Accelerate Myeloid Drug Translation 4:15 pm

What endpoints, comparators, and biomarkers regulators are prioritizing after a wave of failures in CD47, ILT, and TREM2-based programs How to structure early-phase trials and IND packages to manage risk, especially for novel myeloid reprogramming or depletion strategies What funders (VCs, pharma partners, government) need to see in terms of differentiation, scalability, and patient stratification…Read more

day: Conference Day One

Targeting Clever-1 in Macrophage-Driven Disease: Clinical Lessons from MDS & Beyond 5:00 pm

MDS and AML are cancers of the macrophage lineage, in which all cancer cells express Clever-1, a master receptor of immunosuppression on macrophages Targeting Clever-1 in MDS has proven extremely effective to overcome treatment resistance to standard of care agents Clever-1 is found on TAMs in a number of aggressive and treatment resistant cancers and…Read more

day: Conference Day One